Clinical Trials · NCT04787744
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- Phase
- Phase 2/Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- VA Office of Research and Development
- Enrollment
- 378
- Start date
- Jul 2021
- Locations
- 20 sites, United States
- Primary endpoint
- Castration-resistant prostate cancer-free survival (CRPC-free survival)